Navigation Links
Mirixa Corporation Announces MirixaEdge(SM)
Date:10/19/2009

NEW ORLEANS, Oct. 19 /PRNewswire/ -- NCPA 111th Annual Convention -- Mirixa Corporation, the leader in targeted pharmacy-based patient care services, has announced the launch of MirixaEdge(SM). Previewed to independent pharmacists at the National Community Pharmacists Association's annual convention, MirixaEdge enables pharmacists to design their own patient care programs for any of their patients regardless of health plan, employer, or age.

MirixaEdge capitalizes on the nation's leading web-based clinical platform, MirixaPro(SM), which is available to over 40,000 contracted pharmacies nationwide to identify patient health care issues, highlight potential medication-related interactions, and encourage standardized care by pharmacists. MirixaEdge helps jumpstart the process of personalized program creation by providing pharmacists with pre-defined templates for conditions such as diabetes, asthma, and cardiovascular disease. Pharmacists can also take advantage of a template for medication therapy management. Additional MirixaEdge templates are planned.

"MirixaEdge helps pharmacists improve health outcomes for their patients, drive down health care costs and provide greater access to care," said Rick Solano, Mirixa's Chief Executive Officer. "The product expands patient care opportunities for community pharmacy and enables pharmacists to proactively engage their patients in the kind of dialogue that drives customer loyalty and trust."

MirixaEdge provides pharmacies with a standardized platform on which to establish their unique pharmacy patient care programs, capture outcomes measurements, and use that information to educate patients about their health issues.

A select group of MirixaPro participating pharmacies have participated in beta testing of MirixaEdge. One member of the pilot group, Justin Wilson, PharmD., of Valu-Med Pharmacy in Midwest City, OK, anticipates that using MirixaEdge will enhance customer relations and notes, "This tool will provide our pharmacy with a mechanism to proactively engage patients in a dialogue about their medication. By initiating a discussion, our pharmacists will be better able to advise and educate the patient while at the same time encouraging them to adhere to their medication regime and to focus on healthy lifestyle choices."

About Mirixa

Mirixa Corporation, sponsored by the National Community Pharmacists Association (NCPA), is the leader in targeted patient care services delivered via the nation's largest pharmacy-based patient care network. Dedicated to improving patients' health, Mirixa enables the health care community to deliver patient care services through retail pharmacy. The MirixaPro(SM) web-based clinical platform is used by pharmacists to deliver standardized patient care services. For more information, please visit www.Mirixa.com.

    Contact:     Anne Marie Heil
                 610-933-8065 (o)
                 484-886-7540 (c)
                 amheil@amheil.com

SOURCE Mirixa Corporation


'/>"/>
SOURCE Mirixa Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Mirixa Corporation Announces Key Pharmacy Network Hire
2. WebMD and HLTH Corporation to Webcast Annual Meetings of Stockholders
3. Baxa Corporation Signs Exclusive Distribution Agreement With Leading Pharmaceutical Corporation in Peoples Republic of China
4. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
5. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference
6. CEL-SCI Corporation Releases Letter to Shareholders
7. ETEX Corporation Announces Additional FDA Clearance For EquivaBone(R), The First Hard Setting Osteoconductive and Osteoinductive Bone Graft Substitute.
8. Clinical Logistics Enters Partnership with Gentris Corporation
9. Exsulin Corporation Announces Next Phase II Trial of Novel Islet Regeneration Treatment in Type 1 Diabetes
10. Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting on the Primary Treatment of Early Breast Cancer
11. Celladon Corporation Announces Presentation of First-in-Human Gene Transfer to Treat Heart Failure at the 12th Annual Meeting of the American Society of Gene Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC ... by obtaining investment capital for emerging technology companies. SCP has delivered investment ... resulted in more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... human induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces ... Medium. The PluriQ™ G9™ Gene Editing System is a complete system ...
Breaking Medicine News(10 mins):